Floatz logo

10 assets in Male Breast Carcinoma

Therapeutic assets addressing Male Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tamoxifen
Male Breast Carcinoma
Jose Pablo LeoneP3BB (70)
Goserelin
Male Breast Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoP3BB (67)
Palbociclib
Male Breast Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoP2B (57)
Abemaciclib
Male Breast Carcinoma
Jose Pablo LeoneP2CCC (53)
Anastrozole
Male Breast Carcinoma
Jose Pablo LeoneP2CCC (53)
Degarelix
Male Breast Carcinoma
Jose Pablo LeoneP2CCC (53)
Wokvac Vaccine
Male Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (53)
Ribociclib
Male Breast Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoP1CC (47)
Letrozole
Male Breast Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoP1CC (46)
Testosterone Undecylate
Male Breast Carcinoma
University Medical Center GroningenN/AD (30)